CD24-H7

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameCD24-H7

Drug Alias NameN/A

ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)

Mechanisms of ActionTransferrin receptor protein 1 bindersSignal transducer CD24 degraders

TargetsTransferrin receptor protein 1Signal transducer CD24

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesFourth Military Medical University Of Chinese People'S Liberation Army

China Registration ClassN/A

Develop Information

Active CompaniesFourth Military Medical University Of Chinese People'S Liberation Army

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A